Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UCB Pharma
Age
16–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult
in- or out-subjects suffering from partial onset seizures according to the ILAE classification of Epileptic Seizures;
intake of levetiracetam as an adjunctive antiepileptic oral treatment in addition to one or two antiepileptic drugs (AED).
You may not be if
Had problems of venous accessibility;
showed safety issues related to the administration of one of the concomitant AEDs requiring medical intervention;
clinically significant ECG/lab abnormalities;
administered vigabatrine;
administered felbamate for less than 18 months;
had contraindication to any component of the study medication treatment as IV formulation or known allergic reaction to or intolerance of pyrrolidone derivatives.
Clareo Health | Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures
